Revitalist Signs 10 Additional LOI’s to Expand Clinic Network
VANCOUVER, BC, September 9, 2021 – REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) is pleased to announce it has signed ten non-binding letters of intent (“LOI”) with leading expert providers across the United States; these options on licenses are designed to expand the Company’s footprint of innovative patient centered ketamine clinics. Revitalist is uniquely structured around its scalable clinic model that allows established and experienced providers to support new providers in the Company’s continued buildout across the United States. “Our clinic network supports each other in growth, marketing, operations and structure, which all contribute to Revitalist becoming a leader in the psychedelic wellness industry,” reports Revitalist Founder and Chief Executive Officer, Kathryn Walker. Ketamine Media’s strategic partnership with Revitalist allows for expansion into the digital media space as well as the rapidly growing advocacy and education aspect of all psychedelics by owning over 1000 digital properties. “The unique market space we acquired years ago continues to pay dividends as growth becomes more evident across the board. This allows such a diverse approach to capturing the necessary data to support Revitalist’s expansive growth,” commented Anthony El Chibani, Managing Partner of Ketamine Media. The ten non-binding LOIs were executed in April 2021 with the expectation that the definitive option agreements will close in the next 30 days, The cities and states for these locations are as follows:
- Orlando, Florida (2)
- Jacksonville, Florida (2)
- St Petersburg, Florida
- Ormond Beach, Florida
- Carbondale, Illinois
- Clarksville, Tennessee
- Detroit Metro, Michigan
- Dallas, Texas
Revitalist Lifestyle and Wellness Ltd. is a publicly traded (CSE: CALM) company, headquartered in Knoxville, Tennessee, with four clinics operating across the United States and expanding. Revitalist is dedicated to empowering individuals toward an improved quality of well-being through a combination of comprehensive care and future-centric treatments provided by medical professionals, mental health experts, and chronic pain specialists. Since opening their first clinic in 2018, Revitalist has provided over 7,000 infusions for patients suffering from treatment-resistant conditions. Additionally, Revitalist offers a number of lifestyle optimization services and vitamin infusions that can bring anyone closer to total wellness. On Behalf of the Board Kathryn Walker Chief Executive Officer For further information please contact: Revitalist Lifestyle and Wellness Ltd. Investor Relations IR@revitalist.com
For additional information and to be added to the Company’s mailing list, please click here.
Forward Looking Statements
This news release contains forward-looking statements and information within the meaning of applicable securities legislation. Often, but not always, forward-looking statements and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward looking statements or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Revitalist to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements or information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.